Advanced imaging techniques help determine cause of brain bleeds
A recent study showed that specific imaging patterns could help physicians determine the cause of neonatal brain bleeds.
A recent study showed that specific imaging patterns could help physicians determine the cause of neonatal brain bleeds.
Subamniotic hemorrhage, a possible FNAIT complication, poses significant diagnostic challenges, particularly when it presents before birth.
Families of patients with NICU stays due to severe conditions reported telemedicine appointments improved adaptation after discharge.
The addition of a sugar molecule (fucosylation) to IgG antibodies could help in determining the severity of alloimmune diseases like FNAIT.
In the study, FNAIT was often associated with other conditions such as preeclampsia, neonatal sepsis and necrotizing enterocolitis.
In a recent study, researchers identified the clinical signs that may point to a rare subtype of intracranial hemorrhage.
Rallybio announced its clinical trial investigating the drug RLYB212, intended for the prevention of FNAIT, was discontinued.
Researchers studied a rare case of prolonged fetal and neonatal alloimmune thrombocytopenia (FNAIT) caused by three different antibody types.
Platelet transfusions are often required to treat FNAIT, however recent evidence suggests that they could produce serious complications.
A case of a newborn with thrombocytopenia illustrated the value of considering all possible FNAIT differential diagnoses, including HLH.